scispace - formally typeset
C

Celia P. Kaplan

Researcher at University of California, San Francisco

Publications -  144
Citations -  4362

Celia P. Kaplan is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Breast cancer & Population. The author has an hindex of 32, co-authored 135 publications receiving 3899 citations. Previous affiliations of Celia P. Kaplan include University of California & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results

TL;DR: Whether the use of hormone therapy has changed among postmenopausal women as a result of the publication of the HERS and the WHI is examined, and whether patterns of use differ by patient characteristics is examined.
Journal ArticleDOI

The Association of Race, Socioeconomic Status, and Health Insurance Status With the Prevalence of Overweight Among Children and Adolescents

TL;DR: There are substantial racial differences in the prevalence of overweight for children and adolescents and health insurance status is associated with the prevalenceof overweight among adolescents.
Journal ArticleDOI

Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.

TL;DR: Transportation incentives emerged as the dominant intervention condition among patient subgroups that can be characterized as more disadvantaged socioeconomically and at higher risk of developing cervical cancer, including patients receiving care from the county health department and patients with less severe pap smear results.
Journal ArticleDOI

Barriers to Colorectal Cancer Screening in Latino and Vietnamese Americans: Compared with Non-Latino White Americans

TL;DR: Differences in attitudes and perceived barriers suggest that culturally tailored interventions to increase CRC screening will be useful in these populations.
Journal ArticleDOI

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).

TL;DR: The COMET trial will determine whether there may be some women who do not substantially benefit from current GCC and who could thus be safely managed with AS, and to gather evidence to help future patients consider the range of treatment choices for low-risk DCIS, from standard therapies to AS.